Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
You can read the abstract at Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial A group of researchers conducted a phase 3 clinical trial to examine the efficacy and safety of subcutaneous semaglutide 2.4 mg once per week, semaglutide 1.0 mg (licensed for the treatment of diabetes), and placebo in managing weight in an adult population who were overweight or obese and have type 2 diabetes
Step 3: Draw the Bacteriostatic Water Inject the air into the water vial, invert it, and draw out the exact amount of water your ratio calls for
Pregnant, breastfeeding, or kidney/liver patients should avoid this treatment
Ozempic is also FDA-approved for type 2 diabetes, while its cousin Wegovy (a higher dose of the same drug) is officially approved for chronic weight management
